Study of EVO756 in Adults With Migraine
Recruiting
Phase 2
Interventional Study
Migraine
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 64
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 330 (estimated)
- Sponsor
- Evommune, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Key Inclusion Criteria:
* Adults aged 18 to \<65 years
* Migraine with or without aura, per ICHD-3 criteria
* History of failure with prior preventive migraine treatments
* Not currently using migraine preventive therapy
Key Exclusion Criteria:
* Difficulty distinguishing migraine from other head…
Contacts